DNA methylation alterations in muscle of critically ill patients
Abstract Background Intensive care unit (ICU)‐acquired weakness can persist beyond ICU stay and has been associated with long‐term functional impairment of ICU survivors. Recently, DNA methylation alterations were found in the blood of ICU patients, partially explaining long‐term developmental impai...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.12970 |
| _version_ | 1797204314188414976 |
|---|---|
| author | Lisa Van Dyck Fabian Güiza Inge Derese Lies Pauwels Michaël P. Casaer Greet Hermans Pieter J. Wouters Greet Van den Berghe Ilse Vanhorebeek |
| author_facet | Lisa Van Dyck Fabian Güiza Inge Derese Lies Pauwels Michaël P. Casaer Greet Hermans Pieter J. Wouters Greet Van den Berghe Ilse Vanhorebeek |
| author_sort | Lisa Van Dyck |
| collection | DOAJ |
| description | Abstract Background Intensive care unit (ICU)‐acquired weakness can persist beyond ICU stay and has been associated with long‐term functional impairment of ICU survivors. Recently, DNA methylation alterations were found in the blood of ICU patients, partially explaining long‐term developmental impairment of critically ill children. As illness‐induced aberrant DNA methylation theoretically could also be involved in long‐term weakness, we investigated whether the DNA methylation signature in muscle of adult critically ill patients differs from that in muscle of healthy controls. Methods Genome‐wide methylation was determined (Infinium® HumanMethylationEPIC BeadChips) in DNA extracted from skeletal muscle biopsies that had been collected on Day 8 ± 1 in ICU from 172 EPaNIC‐trial patients [66% male sex, median age 62.7 years, median body mass index (BMI) 25.9 kg/m2] and 20 matched healthy controls (70% male sex, median age 58.0 years, median BMI 24.4 kg/m2). Methylation status of individual cytosine–phosphate–guanine (CpG) sites of patients and controls was compared with F‐tests, using the Benjamini–Hochberg false discovery rate to correct for multiple comparisons. Differential methylation of DNA regions was assessed with bump hunting, with 1000 permutations assessing uncertainty, expressed as family‐wise error rate. Gene expression was investigated for 10 representative affected genes. Results In DNA from ICU patients, 565 CpG sites, associated with 400 unique genes, were differentially methylated as compared with controls (average difference 3.2 ± 0.1% ranging up to 16.9%, P < 0.00005). Many of the associated genes appeared highly relevant for muscle structure and function/weakness, including genes involved in myogenesis, muscle regeneration, nerve/muscle membrane excitability, muscle denervation/re‐innervation, axon guidance/myelination/degeneration/regeneration, synapse function, ion channelling with especially calcium signalling, metabolism (glucose, protein, and fat), insulin signalling, neuroendocrine hormone regulation, mitochondrial function, autophagy, apoptosis, oxidative stress, Wnt signalling, transcription regulation, muscle fat infiltration during regeneration, and fibrosis. In patients as compared with controls, we also identified two hypomethylated regions, spanning 18 and 3 CpG sites in the promoters of the HIC1 and NADK2 genes, respectively (average differences 5.8 ± 0.01% and 12.1 ± 0.04%, family‐wise error rate <0.05). HIC1 and NADK2 play important roles in muscle regeneration and postsynaptic acetylcholine receptors and in mitochondrial processes, respectively. Nine of 10 investigated genes containing DNA methylation alterations were differentially expressed in patients as compared with controls (P ≤ 0.03). Conclusions Critically ill patients present with a different DNA methylation signature in skeletal muscle as compared with healthy controls, which in theory could provide a biological basis for long‐term persistence of weakness in ICU survivors. Trial registration: ClinicalTrials.gov: NCT00512122, registered on 31 July 2007. |
| first_indexed | 2024-04-12T13:15:04Z |
| format | Article |
| id | doaj.art-4a482e5e7d98471fa8ae22497fcf4bf9 |
| institution | Directory Open Access Journal |
| issn | 2190-5991 2190-6009 |
| language | English |
| last_indexed | 2024-04-24T08:33:15Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Cachexia, Sarcopenia and Muscle |
| spelling | doaj.art-4a482e5e7d98471fa8ae22497fcf4bf92024-04-16T18:10:50ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092022-06-011331731174010.1002/jcsm.12970DNA methylation alterations in muscle of critically ill patientsLisa Van Dyck0Fabian Güiza1Inge Derese2Lies Pauwels3Michaël P. Casaer4Greet Hermans5Pieter J. Wouters6Greet Van den Berghe7Ilse Vanhorebeek8Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumClinical Division of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine KU Leuven Leuven BelgiumAbstract Background Intensive care unit (ICU)‐acquired weakness can persist beyond ICU stay and has been associated with long‐term functional impairment of ICU survivors. Recently, DNA methylation alterations were found in the blood of ICU patients, partially explaining long‐term developmental impairment of critically ill children. As illness‐induced aberrant DNA methylation theoretically could also be involved in long‐term weakness, we investigated whether the DNA methylation signature in muscle of adult critically ill patients differs from that in muscle of healthy controls. Methods Genome‐wide methylation was determined (Infinium® HumanMethylationEPIC BeadChips) in DNA extracted from skeletal muscle biopsies that had been collected on Day 8 ± 1 in ICU from 172 EPaNIC‐trial patients [66% male sex, median age 62.7 years, median body mass index (BMI) 25.9 kg/m2] and 20 matched healthy controls (70% male sex, median age 58.0 years, median BMI 24.4 kg/m2). Methylation status of individual cytosine–phosphate–guanine (CpG) sites of patients and controls was compared with F‐tests, using the Benjamini–Hochberg false discovery rate to correct for multiple comparisons. Differential methylation of DNA regions was assessed with bump hunting, with 1000 permutations assessing uncertainty, expressed as family‐wise error rate. Gene expression was investigated for 10 representative affected genes. Results In DNA from ICU patients, 565 CpG sites, associated with 400 unique genes, were differentially methylated as compared with controls (average difference 3.2 ± 0.1% ranging up to 16.9%, P < 0.00005). Many of the associated genes appeared highly relevant for muscle structure and function/weakness, including genes involved in myogenesis, muscle regeneration, nerve/muscle membrane excitability, muscle denervation/re‐innervation, axon guidance/myelination/degeneration/regeneration, synapse function, ion channelling with especially calcium signalling, metabolism (glucose, protein, and fat), insulin signalling, neuroendocrine hormone regulation, mitochondrial function, autophagy, apoptosis, oxidative stress, Wnt signalling, transcription regulation, muscle fat infiltration during regeneration, and fibrosis. In patients as compared with controls, we also identified two hypomethylated regions, spanning 18 and 3 CpG sites in the promoters of the HIC1 and NADK2 genes, respectively (average differences 5.8 ± 0.01% and 12.1 ± 0.04%, family‐wise error rate <0.05). HIC1 and NADK2 play important roles in muscle regeneration and postsynaptic acetylcholine receptors and in mitochondrial processes, respectively. Nine of 10 investigated genes containing DNA methylation alterations were differentially expressed in patients as compared with controls (P ≤ 0.03). Conclusions Critically ill patients present with a different DNA methylation signature in skeletal muscle as compared with healthy controls, which in theory could provide a biological basis for long‐term persistence of weakness in ICU survivors. Trial registration: ClinicalTrials.gov: NCT00512122, registered on 31 July 2007.https://doi.org/10.1002/jcsm.12970Critical illnessIntensive care unit‐acquired muscle weaknessMuscleDNA methylationEpigenetics |
| spellingShingle | Lisa Van Dyck Fabian Güiza Inge Derese Lies Pauwels Michaël P. Casaer Greet Hermans Pieter J. Wouters Greet Van den Berghe Ilse Vanhorebeek DNA methylation alterations in muscle of critically ill patients Journal of Cachexia, Sarcopenia and Muscle Critical illness Intensive care unit‐acquired muscle weakness Muscle DNA methylation Epigenetics |
| title | DNA methylation alterations in muscle of critically ill patients |
| title_full | DNA methylation alterations in muscle of critically ill patients |
| title_fullStr | DNA methylation alterations in muscle of critically ill patients |
| title_full_unstemmed | DNA methylation alterations in muscle of critically ill patients |
| title_short | DNA methylation alterations in muscle of critically ill patients |
| title_sort | dna methylation alterations in muscle of critically ill patients |
| topic | Critical illness Intensive care unit‐acquired muscle weakness Muscle DNA methylation Epigenetics |
| url | https://doi.org/10.1002/jcsm.12970 |
| work_keys_str_mv | AT lisavandyck dnamethylationalterationsinmuscleofcriticallyillpatients AT fabianguiza dnamethylationalterationsinmuscleofcriticallyillpatients AT ingederese dnamethylationalterationsinmuscleofcriticallyillpatients AT liespauwels dnamethylationalterationsinmuscleofcriticallyillpatients AT michaelpcasaer dnamethylationalterationsinmuscleofcriticallyillpatients AT greethermans dnamethylationalterationsinmuscleofcriticallyillpatients AT pieterjwouters dnamethylationalterationsinmuscleofcriticallyillpatients AT greetvandenberghe dnamethylationalterationsinmuscleofcriticallyillpatients AT ilsevanhorebeek dnamethylationalterationsinmuscleofcriticallyillpatients |